谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression.

Anja Welt,Marcel Wiesweg,Sarah Theurer,Wolfgang Abenhardt,Matthias Groschek,Lothar Müller,Jan Schröder,Mitra Tewes,Marco Chiabudini,Karin Potthoff,Agnes Bankfalvi,Norbert Marschner,Martin Schuler,Frank Breitenbücher

CANCER MEDICINE（2020）

引用 9|浏览24
暂无评分
关键词
breast cancer,buparlisib,clinical trial,phase II,drug therapy,PI3K
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要